APO Research

APO RESEARCH · REPORT

Pathology Image Analysis Software

Selected research

Market Analysis & Forecast

Global Pathology Image Analysis Software Market Analysis and Forecast 2026-2032

Market perspective

The global Pathology Image Analysis Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pathology Image Analysis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pathology Image Analysis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pathology Image Analysis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pathology Image Analysis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pathology Image Analysis Software include Aiforia, Visiopharm, Indica Labs, BMD Software, Biocellvia, HeteroGenius, MLM Medical Labs, Sectra and Augmentiqs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pathology Image Analysis Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pathology Image Analysis Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Pathology Image Analysis Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pathology Image Analysis Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pathology Image Analysis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pathology Image Analysis Software revenue, projected growth trends, production technology, application and end-user industry.

Pathology Image Analysis Software Segment by Company

Aiforia

Visiopharm

Indica Labs

BMD Software

Biocellvia

HeteroGenius

MLM Medical Labs

Sectra

Augmentiqs

3DHISTECH Ltd.

Gestalt

KFBIO

Proscia

Pathology Image Analysis Software Segment by Type

On-premise

Cloud Based

Pathology Image Analysis Software Segment by Application

Pathological Diagnosis

Clinical Laboratory

Drug Discovery

Others

Pathology Image Analysis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Image Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathology Image Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Image Analysis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pathology Image Analysis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pathology Image Analysis Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pathology Image Analysis Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pathology Image Analysis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-premise Major Player Table 3. Cloud Based Major Player Table 4. Global Pathology Image Analysis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pathological Diagnosis Major Player Table 6. Clinical Laboratory Major Player Table 7. Drug Discovery Major Player Table 8. Others Major Player Table 9. Pathology Image Analysis Software Industry Trends Table 10. Pathology Image Analysis Software Industry Drivers Table 11. Pathology Image Analysis Software Industry Opportunities and Challenges Table 12. Pathology Image Analysis Software Industry Restraints Table 13. Global Pathology Image Analysis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pathology Image Analysis Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pathology Image Analysis Software Market Share by Region (2021-2026) Table 16. Global Pathology Image Analysis Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pathology Image Analysis Software Market Share by Region (2027-2032) Table 18. Global Pathology Image Analysis Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pathology Image Analysis Software Revenue Market Share by Players (2021-2026) Table 20. Global Pathology Image Analysis Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pathology Image Analysis Software Key Players Headquarters & Area Served Table 22. Global Pathology Image Analysis Software Players, Product Type & Application Table 23. Global Pathology Image Analysis Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pathology Image Analysis Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pathology Image Analysis Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pathology Image Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pathology Image Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pathology Image Analysis Software Revenue Market Share by Type (2021-2026) Table 30. Global Pathology Image Analysis Software Revenue Market Share by Type (2027-2032) Table 31. Global Pathology Image Analysis Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pathology Image Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pathology Image Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pathology Image Analysis Software Revenue Market Share by Application (2021-2026) Table 35. Global Pathology Image Analysis Software Revenue Market Share by Application (2027-2032) Table 36. Aiforia Company Information Table 37. Aiforia Business Overview Table 38. Aiforia Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Aiforia Pathology Image Analysis Software Product Portfolio Table 40. Aiforia Recent Development Table 41. Visiopharm Company Information Table 42. Visiopharm Business Overview Table 43. Visiopharm Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Visiopharm Pathology Image Analysis Software Product Portfolio Table 45. Visiopharm Recent Development Table 46. Indica Labs Company Information Table 47. Indica Labs Business Overview Table 48. Indica Labs Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Indica Labs Pathology Image Analysis Software Product Portfolio Table 50. Indica Labs Recent Development Table 51. BMD Software Company Information Table 52. BMD Software Business Overview Table 53. BMD Software Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. BMD Software Pathology Image Analysis Software Product Portfolio Table 55. BMD Software Recent Development Table 56. Biocellvia Company Information Table 57. Biocellvia Business Overview Table 58. Biocellvia Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Biocellvia Pathology Image Analysis Software Product Portfolio Table 60. Biocellvia Recent Development Table 61. HeteroGenius Company Information Table 62. HeteroGenius Business Overview Table 63. HeteroGenius Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. HeteroGenius Pathology Image Analysis Software Product Portfolio Table 65. HeteroGenius Recent Development Table 66. MLM Medical Labs Company Information Table 67. MLM Medical Labs Business Overview Table 68. MLM Medical Labs Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. MLM Medical Labs Pathology Image Analysis Software Product Portfolio Table 70. MLM Medical Labs Recent Development Table 71. Sectra Company Information Table 72. Sectra Business Overview Table 73. Sectra Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Sectra Pathology Image Analysis Software Product Portfolio Table 75. Sectra Recent Development Table 76. Augmentiqs Company Information Table 77. Augmentiqs Business Overview Table 78. Augmentiqs Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Augmentiqs Pathology Image Analysis Software Product Portfolio Table 80. Augmentiqs Recent Development Table 81. 3DHISTECH Ltd. Company Information Table 82. 3DHISTECH Ltd. Business Overview Table 83. 3DHISTECH Ltd. Pathology Image Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. 3DHISTECH Ltd. Pathology Image Analysis Software Product Portfolio Table 85. 3DHISTECH Ltd. Recent Development Table 86. Gestalt Company Information Table 87. Gestalt Business Overview Table 88. Gestalt Pathology Image Analysis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Gestalt Pathology Image Analysis Software Product Portfolio Table 90. Gestalt Recent Development Table 91. KFBIO Company Information Table 92. KFBIO Business Overview Table 93. KFBIO Pathology Image Analysis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. KFBIO Pathology Image Analysis Software Product Portfolio Table 95. KFBIO Recent Development Table 96. Proscia Company Information Table 97. Proscia Business Overview Table 98. Proscia Pathology Image Analysis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Proscia Pathology Image Analysis Software Product Portfolio Table 100. Proscia Recent Development Table 101. North America Pathology Image Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Pathology Image Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Pathology Image Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Pathology Image Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Pathology Image Analysis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Pathology Image Analysis Software Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Pathology Image Analysis Software Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Pathology Image Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Pathology Image Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Pathology Image Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Pathology Image Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Pathology Image Analysis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Pathology Image Analysis Software Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Pathology Image Analysis Software Revenue by Country (US$ Million) & (2027-2032) Table 115. China Pathology Image Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 116. China Pathology Image Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 117. China Pathology Image Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 118. China Pathology Image Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Pathology Image Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Pathology Image Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Pathology Image Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Pathology Image Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Pathology Image Analysis Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Pathology Image Analysis Software Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Pathology Image Analysis Software Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Pathology Image Analysis Software Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Pathology Image Analysis Software Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Pathology Image Analysis Software Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Pathology Image Analysis Software Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Pathology Image Analysis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Pathology Image Analysis Software Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Pathology Image Analysis Software Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Pathology Image Analysis Software Image Figure 2. Global Pathology Image Analysis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathology Image Analysis Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-premise Image Figure 5. Cloud Based Image Figure 6. Global Pathology Image Analysis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pathology Image Analysis Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pathological Diagnosis Image Figure 9. Clinical Laboratory Image Figure 10. Drug Discovery Image Figure 11. Others Image Figure 12. Global Pathology Image Analysis Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Pathology Image Analysis Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pathology Image Analysis Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pathology Image Analysis Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pathology Image Analysis Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pathology Image Analysis Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pathology Image Analysis Software Revenue Market Share by Type (2021-2032) Figure 20. Global Pathology Image Analysis Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pathology Image Analysis Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pathology Image Analysis Software Revenue Market Share by Application (2021-2032) Figure 23. North America Pathology Image Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pathology Image Analysis Software Revenue Share by Type (2021-2032) Figure 25. North America Pathology Image Analysis Software Revenue Share by Application (2021-2032) Figure 26. North America Pathology Image Analysis Software Revenue Share by Country (2021-2032) Figure 27. United States Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pathology Image Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pathology Image Analysis Software Revenue Share by Type (2021-2032) Figure 32. Europe Pathology Image Analysis Software Revenue Share by Application (2021-2032) Figure 33. Europe Pathology Image Analysis Software Revenue Share by Country (2021-2032) Figure 34. Germany Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pathology Image Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pathology Image Analysis Software Revenue Share by Type (2021-2032) Figure 44. China Pathology Image Analysis Software Revenue Share by Application (2021-2032) Figure 45. Asia Pathology Image Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pathology Image Analysis Software Revenue Share by Type (2021-2032) Figure 47. Asia Pathology Image Analysis Software Revenue Share by Application (2021-2032) Figure 48. Asia Pathology Image Analysis Software Revenue Share by Region (2021-2032) Figure 49. Japan Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pathology Image Analysis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pathology Image Analysis Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Pathology Image Analysis Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Pathology Image Analysis Software Revenue Share by Country (2021-2032) Figure 59. Brazil Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pathology Image Analysis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • On-premise
  • Cloud Based
Applications
  • Pathological Diagnosis
  • Clinical Laboratory
  • Drug Discovery
  • Others
Companies covered
  • Aiforia
  • Visiopharm
  • Indica Labs
  • BMD Software
  • Biocellvia
  • HeteroGenius
  • MLM Medical Labs
  • Sectra
  • Augmentiqs
  • 3DHISTECH Ltd.
  • Gestalt
  • KFBIO
  • Proscia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pathology Image Analysis Software Market by Type
  3. 1.2.1 Global Pathology Image Analysis Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-premise
  5. 1.2.3 Cloud Based
  6. 1.3 Pathology Image Analysis Software Market by Application
  7. 1.3.1 Global Pathology Image Analysis Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pathological Diagnosis
  9. 1.3.3 Clinical Laboratory
  10. 1.3.4 Drug Discovery
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pathology Image Analysis Software Market Dynamics
  1. 2.1 Pathology Image Analysis Software Industry Trends
  2. 2.2 Pathology Image Analysis Software Industry Drivers
  3. 2.3 Pathology Image Analysis Software Industry Opportunities and Challenges
  4. 2.4 Pathology Image Analysis Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pathology Image Analysis Software Market Perspective (2021-2032)
  2. 3.2 Global Pathology Image Analysis Software Growth Trends by Region
  3. 3.2.1 Global Pathology Image Analysis Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pathology Image Analysis Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Pathology Image Analysis Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pathology Image Analysis Software Revenue by Players
  2. 4.1.1 Global Pathology Image Analysis Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Pathology Image Analysis Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pathology Image Analysis Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pathology Image Analysis Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pathology Image Analysis Software Key Players Headquarters & Area Served
  7. 4.4 Global Pathology Image Analysis Software Players, Product Type & Application
  8. 4.5 Global Pathology Image Analysis Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pathology Image Analysis Software Market CR5 and HHI
  11. 4.6.3 2025 Pathology Image Analysis Software Tier 1, Tier 2, and Tier 3
5 Pathology Image Analysis Software Market Size by Type
  1. 5.1 Global Pathology Image Analysis Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pathology Image Analysis Software Revenue by Type (2021-2032)
  3. 5.3 Global Pathology Image Analysis Software Revenue Market Share by Type (2021-2032)
6 Pathology Image Analysis Software Market Size by Application
  1. 6.1 Global Pathology Image Analysis Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pathology Image Analysis Software Revenue by Application (2021-2032)
  3. 6.3 Global Pathology Image Analysis Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aiforia
  2. 7.1.1 Aiforia Company Information
  3. 7.1.2 Aiforia Business Overview
  4. 7.1.3 Aiforia Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aiforia Pathology Image Analysis Software Product Portfolio
  6. 7.1.5 Aiforia Recent Developments
  7. 7.2 Visiopharm
  8. 7.2.1 Visiopharm Company Information
  9. 7.2.2 Visiopharm Business Overview
  10. 7.2.3 Visiopharm Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Visiopharm Pathology Image Analysis Software Product Portfolio
  12. 7.2.5 Visiopharm Recent Developments
  13. 7.3 Indica Labs
  14. 7.3.1 Indica Labs Company Information
  15. 7.3.2 Indica Labs Business Overview
  16. 7.3.3 Indica Labs Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Indica Labs Pathology Image Analysis Software Product Portfolio
  18. 7.3.5 Indica Labs Recent Developments
  19. 7.4 BMD Software
  20. 7.4.1 BMD Software Company Information
  21. 7.4.2 BMD Software Business Overview
  22. 7.4.3 BMD Software Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BMD Software Pathology Image Analysis Software Product Portfolio
  24. 7.4.5 BMD Software Recent Developments
  25. 7.5 Biocellvia
  26. 7.5.1 Biocellvia Company Information
  27. 7.5.2 Biocellvia Business Overview
  28. 7.5.3 Biocellvia Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Biocellvia Pathology Image Analysis Software Product Portfolio
  30. 7.5.5 Biocellvia Recent Developments
  31. 7.6 HeteroGenius
  32. 7.6.1 HeteroGenius Company Information
  33. 7.6.2 HeteroGenius Business Overview
  34. 7.6.3 HeteroGenius Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 HeteroGenius Pathology Image Analysis Software Product Portfolio
  36. 7.6.5 HeteroGenius Recent Developments
  37. 7.7 MLM Medical Labs
  38. 7.7.1 MLM Medical Labs Company Information
  39. 7.7.2 MLM Medical Labs Business Overview
  40. 7.7.3 MLM Medical Labs Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 MLM Medical Labs Pathology Image Analysis Software Product Portfolio
  42. 7.7.5 MLM Medical Labs Recent Developments
  43. 7.8 Sectra
  44. 7.8.1 Sectra Company Information
  45. 7.8.2 Sectra Business Overview
  46. 7.8.3 Sectra Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sectra Pathology Image Analysis Software Product Portfolio
  48. 7.8.5 Sectra Recent Developments
  49. 7.9 Augmentiqs
  50. 7.9.1 Augmentiqs Company Information
  51. 7.9.2 Augmentiqs Business Overview
  52. 7.9.3 Augmentiqs Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Augmentiqs Pathology Image Analysis Software Product Portfolio
  54. 7.9.5 Augmentiqs Recent Developments
  55. 7.10 3DHISTECH Ltd.
  56. 7.10.1 3DHISTECH Ltd. Company Information
  57. 7.10.2 3DHISTECH Ltd. Business Overview
  58. 7.10.3 3DHISTECH Ltd. Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 3DHISTECH Ltd. Pathology Image Analysis Software Product Portfolio
  60. 7.10.5 3DHISTECH Ltd. Recent Developments
  61. 7.11 Gestalt
  62. 7.11.1 Gestalt Company Information
  63. 7.11.2 Gestalt Business Overview
  64. 7.11.3 Gestalt Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Gestalt Pathology Image Analysis Software Product Portfolio
  66. 7.11.5 Gestalt Recent Developments
  67. 7.12 KFBIO
  68. 7.12.1 KFBIO Company Information
  69. 7.12.2 KFBIO Business Overview
  70. 7.12.3 KFBIO Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 KFBIO Pathology Image Analysis Software Product Portfolio
  72. 7.12.5 KFBIO Recent Developments
  73. 7.13 Proscia
  74. 7.13.1 Proscia Company Information
  75. 7.13.2 Proscia Business Overview
  76. 7.13.3 Proscia Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Proscia Pathology Image Analysis Software Product Portfolio
  78. 7.13.5 Proscia Recent Developments
8 North America
  1. 8.1 North America Pathology Image Analysis Software Revenue (2021-2032)
  2. 8.2 North America Pathology Image Analysis Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Pathology Image Analysis Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Pathology Image Analysis Software Revenue by Type (2027-2032)
  5. 8.3 North America Pathology Image Analysis Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Pathology Image Analysis Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Pathology Image Analysis Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Pathology Image Analysis Software Revenue by Application (2027-2032)
  9. 8.5 North America Pathology Image Analysis Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Pathology Image Analysis Software Revenue by Country
  11. 8.6.1 North America Pathology Image Analysis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pathology Image Analysis Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Pathology Image Analysis Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pathology Image Analysis Software Revenue (2021-2032)
  2. 9.2 Europe Pathology Image Analysis Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pathology Image Analysis Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pathology Image Analysis Software Revenue by Type (2027-2032)
  5. 9.3 Europe Pathology Image Analysis Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pathology Image Analysis Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pathology Image Analysis Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pathology Image Analysis Software Revenue by Application (2027-2032)
  9. 9.5 Europe Pathology Image Analysis Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pathology Image Analysis Software Revenue by Country
  11. 9.6.1 Europe Pathology Image Analysis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pathology Image Analysis Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pathology Image Analysis Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pathology Image Analysis Software Revenue (2021-2032)
  2. 10.2 China Pathology Image Analysis Software Revenue by Type (2021-2032)
  3. 10.2.1 China Pathology Image Analysis Software Revenue by Type (2021-2026)
  4. 10.2.2 China Pathology Image Analysis Software Revenue by Type (2027-2032)
  5. 10.3 China Pathology Image Analysis Software Revenue Share by Type (2021-2032)
  6. 10.4 China Pathology Image Analysis Software Revenue by Application (2021-2032)
  7. 10.4.1 China Pathology Image Analysis Software Revenue by Application (2021-2026)
  8. 10.4.2 China Pathology Image Analysis Software Revenue by Application (2027-2032)
  9. 10.5 China Pathology Image Analysis Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pathology Image Analysis Software Revenue (2021-2032)
  2. 11.2 Asia Pathology Image Analysis Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pathology Image Analysis Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pathology Image Analysis Software Revenue by Type (2027-2032)
  5. 11.3 Asia Pathology Image Analysis Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pathology Image Analysis Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pathology Image Analysis Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pathology Image Analysis Software Revenue by Application (2027-2032)
  9. 11.5 Asia Pathology Image Analysis Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pathology Image Analysis Software Revenue by Country
  11. 11.6.1 Asia Pathology Image Analysis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pathology Image Analysis Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pathology Image Analysis Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pathology Image Analysis Software Revenue (2021-2032)
  2. 12.2 SAMEA Pathology Image Analysis Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pathology Image Analysis Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pathology Image Analysis Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pathology Image Analysis Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pathology Image Analysis Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pathology Image Analysis Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pathology Image Analysis Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pathology Image Analysis Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pathology Image Analysis Software Revenue by Country
  11. 12.6.1 SAMEA Pathology Image Analysis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pathology Image Analysis Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pathology Image Analysis Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research